Sayyah-Melli, M <br/><br/>
Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial.  [electronic resource] 

 -  European journal of obstetrics, gynecology, and reproductive biology  Mar 2017 
 - 257-264 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1872-7654 
<br/><br/><label>Standard No.: </label>10.1016/j.ejogrb.2016.11.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--administration & dosage<br/>Aromatase Inhibitors--administration & dosage<br/>Cabergoline<br/>Drug Therapy, Combination<br/>Ergolines--administration & dosage<br/>Female<br/>Humans<br/>Leiomyoma--drug therapy<br/>Letrozole<br/>Middle Aged<br/>Nitriles--administration & dosage<br/>Triazoles--administration & dosage<br/>Uterine Neoplasms--drug therapy<br/>Uterus--drug effects